title: Whither monkeypox vaccination.
abstract: Monkeypox (MPX) is a virulent orthopoxvirus that is endemic in some regions of Central Africa. MPX incidence has been rising since the cessation of routine smallpox immunization. While it causes significant disease, there is limited person-to-person spread, the incidence is still relatively low, and cases are generally restricted to remote areas that are difficult to access. Therefore, initiating vaccine trials or implementing vaccination programs would be challenging. This paper considers the factors that may influence future decisions on whether MPX vaccination should be pursued.
authors.affiliation: University of California, Los Angeles School of Public Health, Los Angeles, CA, USA.
authors.forename: Anne W
authors.initials: AW
authors.lastname: Rimoin
authors.forename: Barney S
authors.initials: BS
authors.lastname: Graham
mesh_terms: D000350:Africa, Central / Q000453:epidemiology; D000818:Animals; D019353:Endemic Diseases; D006801:Humans; D015994:Incidence; D045908:Mpox, Monkeypox / Q000453:epidemiology / Q000517:prevention & control*; D008993:Monkeypox virus / Q000276:immunology / Q000472:pathogenicity; D014611:Vaccination / Q000379:methods*